Aichberger, K. J., Gleixner, K. V., Mirkina, I., Cerny-Reiterer, S., Peter, B., Ferenc, V., Kneidinger, M., Baumgartner, C., Mayerhofer, M., Gruze, A., Pickl, W. F., Sillaber, C. & Valent, P. Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs. Blood 114, 5342-5351, doi:10.1182/blood-2008-08-175190 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19850739

Blomberg, K. E., Boucheron, N., Lindvall, J. M., Yu, L., Raberger, J., Berglof, A., Ellmeier, W. & Smith, C. E. Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells. BMC Genomics 10, 233, doi:10.1186/1471-2164-10-233 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19450280

Bluml, S., Zupkovitz, G., Kirchberger, S., Seyerl, M., Bochkov, V. N., Stuhlmeier, K., Majdic, O., Zlabinger, G. J., Seiser, C. & Stockl, J. Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids. Blood 114, 5481-5489, doi:10.1182/blood-2008-11-191429 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19864645 

Bohm, A., Aichberger, K. J., Mayerhofer, M., Herrmann, H., Florian, S., Krauth, M. T., Derdak, S., Samorapoompichit, P., Sonneck, K., Vales, A., Gleixner, K. V., Pickl, W. F., Sperr, W. R. & Valent, P. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells. Eur J Clin Invest 39, 395-405, doi:10.1111/j.1365-2362.2009.02101.x (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19320940 

Choremi-Papadopoulou, E., Faure, G. C., Malenica, B., Misbah, S. A. & Zlabinger, G. J. Position statement: Assessment strategy for implementation of the Immunology curriculum of the European Board of UEMS Medical Biopathology. Immunol Lett 125, 59-64, doi:10.1016/j.imlet.2009.05.010 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19523980 

Funk, M., Karl, D., Georgopoulos, M., Benesch, T., Sacu, S., Polak, K., Zlabinger, G. J. & Schmidt-Erfurth, U. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 116, 2393-2399, doi:10.1016/j.ophtha.2009.05.039 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19815292

Funk, M., Kriechbaum, K., Prager, F., Benesch, T., Georgopoulos, M., Zlabinger, G. J. & Schmidt-Erfurth, U. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 50, 1025-1032, doi:10.1167/iovs.08-2510 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19060280

Geyeregger, R., Shehata, M., Zeyda, M., Kiefer, F. W., Stuhlmeier, K. M., Porpaczy, E., Zlabinger, G. J., Jager, U. & Stulnig, T. M. Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol 86, 1039-1048, doi:10.1189/jlb.1008663 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19671841

Gleixner, K. V., Mayerhofer, M., Vales, A., Gruze, A., Hormann, G., Cerny-Reiterer, S., Lackner, E., Hadzijusufovic, E., Herrmann, H., Iyer, A. K., Krauth, M. T., Pickl, W. F., Marian, B., Panzer-Grumayer, R., Sillaber, C., Maeda, H., Zielinski, C. & Valent, P. Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy. Curr Cancer Drug Targets 9, 675-689, doi:10.2174/156800909789057024 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19508170

Göbel, F., Taschner, S., Jurkin, J., Konradi, S., Vaculik, C., Richter, S., Kneidinger, D., Mühlbacher, C., Bieglmayer, C., Elbe-Bürger, A., Strobl, H. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood. 114(18):3813-21. doi: 10.1182/blood-2009-03-210484. (2009).
Abstract: https://pubmed.ncbi.nlm.nih.gov/19721012/

Gundacker, N. C., Haudek, V. J., Wimmer, H., Slany, A., Griss, J., Bochkov, V., Zielinski, C., Wagner, O., Stockl, J. & Gerner, C. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J Proteome Res 8, 2799-2811, doi:10.1021/pr8011039 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19351150

Hadzijusufovic, E., Peter, B., Rebuzzi, L., Baumgartner, C., Gleixner, K. V., Gruze, A., Thaiwong, T., Pickl, W. F., Yuzbasiyan-Gurkan, V., Willmann, M. & Valent, P. Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation. Vet Immunol Immunopathol 132, 243-250, doi:10.1016/j.vetimm.2009.05.007 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19505729

Koprulu, A. D. & Ellmeier, W. The role of Tec family kinases in mononuclear phagocytes. Crit Rev Immunol 29, 317-333, doi:10.1615/critrevimmunol.v29.i4.30 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19673686

Kuzmina, Z., Greinix, H. T., Knobler, R., Worel, N., Kouba, M., Weigl, R., Kormoczi, U., Rottal, A., Pohlreich, D., Zielinski, C. & Pickl, W. F. Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Blood 114, 744-746, doi:10.1182/blood-2009-05-221028 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19608761

Leb, V. M., Jahn-Schmid, B., Kueng, H. J., Schmetterer, K. G., Haiderer, D., Neunkirchner, A., Fischer, G. F., Hartl, A., Thalhamer, J., Steinberger, P., Bohle, B., Seed, B. & Pickl, W. F. Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules. J Allergy Clin Immunol 124, 121-128, doi:10.1016/j.jaci.2009.04.008 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19500826 

Leitner, J., Klauser, C., Pickl, W. F., Stockl, J., Majdic, O., Bardet, A. F., Kreil, D. P., Dong, C., Yamazaki, T., Zlabinger, G., Pfistershammer, K. & Steinberger, P. B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. Eur J Immunol 39, 1754-1764, doi:10.1002/eji.200839028 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19544488

Muhammad, A., Schiller, H. B., Forster, F., Eckerstorfer, P., Geyeregger, R., Leksa, V., Zlabinger, G. J., Sibilia, M., Sonnleitner, A., Paster, W. & Stockinger, H. Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome. J Immunol 182, 7672-7680, doi:10.4049/jimmunol.0800691 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19494291

Pfistershammer, K., Lawitschka, A., Klauser, C., Leitner, J., Weigl, R., Heemskerk, M. H., Pickl, W. F., Majdic, O., Bohmig, G. A., Fischer, G. F., Greinix, H. T. & Steinberger, P. Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients. Blood 114, 2323-2332, doi:10.1182/blood-2008-10-183814 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19617579

Platzer, B., Richter, S., Kneidinger, D., Waltenberger, D., Woisetschläger, M., Strobl, H .Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells . J Immunol. 183(1):66-74. doi: 10.4049/jimmunol.0802997. (2009).
Abstract: https://pubmed.ncbi.nlm.nih.gov/19535631/ 

Regelsberger, G., Hoftberger, R., Pickl, W. F., Zlabinger, G. J., Kormoczi, U., Salzer-Muhar, U., Luckner, D., Bodamer, O. A., Mayr, J. A., Muss, W. H., Budka, H. & Bernheimer, H. Danon disease: case report and detection of new mutation. J Inherit Metab Dis 32 Suppl 1, S115-122, doi:10.1007/s10545-009-1097-9 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19588270

Schmidt, U., Abramova, A., Boucheron, N., Eckelhart, E., Schebesta, A., Bilic, I., Kneidinger, M., Unger, B., Hammer, M., Sibilia, M., Valent, P. & Ellmeier, W. The protein tyrosine kinase Tec regulates mast cell function. Eur J Immunol 39, 3228-3238, doi:10.1002/eji.200838839 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19688741

Schrauf, C., Kirchberger, S., Majdic, O., Seyerl, M., Zlabinger, G. J., Stuhlmeier, K. M., Sachet, M., Seipelt, J. & Stockl, J. The ssRNA genome of human rhinovirus induces a type I IFN response but fails to induce maturation in human monocyte-derived dendritic cells. J Immunol 183, 4440-4448, doi:10.4049/jimmunol.0804147 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19734213

Simma, O., Zebedin, E., Neugebauer, N., Schellack, C., Pilz, A., Chang-Rodriguez, S., Lingnau, K., Weisz, E., Putz, E. M., Pickl, W. F., Felzmann, T., Muller, M., Decker, T., Sexl, V. & Stoiber, D. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance. Cancer Res 69, 203-211, doi:10.1158/0008-5472.CAN-08-1705 (2009).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19118004